Goldman Sachs now entwined in healthcare debate

Email LinkedIn
Tools

Goldman Sachs (GS), being Goldman Sachs, draws lot of unwanted attention. Now, it's even a player in the debate over healthcare reform. The Obama Administration (Barack Obama news), according to the New York Times, is seizing on a new report by Goldman Sachs analysts that shows "how insurers can be aggressive in raising prices, they also walk away from clients because competition in the industry is so weak, the White House said. And officials will point to a finding that rate increases ran as high as 50 percent, with most in 'the low- to mid-teens'--far higher than overall inflation."

Is this good or bad for the bank? It perhaps never intended to be made a de facto ally of the administration. But it just might be seen as a PR ploy (public relations news). The results of the report aren't hugely controversial, the conclusions are not earth shattering. In another era, it might been seen as a PR coup, highlighting the high quality of their research. Or is that merely groping for a silver lining?   

For more:
- here's the article

Related Articles:
Many days of $100 million gains at Goldman Sachs
AIG still a Goldman Sachs client
Goldman Sachs' board says no to shareholders
Goldman Sachs on hot seat over Build America Bonds